Low Risk Near Support

Near-Support Strength Scan: Best-of-the-Best Setups (as of 4 Nov 2026)

Disclaimer: This post is for educational and informational purposes only. It is not financial, investment, or trading advice. Past performance is not indicative of future results. Markets are volatile; support levels can fail. Always do your own research, consider your risk tolerance, and consult a qualified advisor before making any investment decisions. The author may or may not hold positions in any of the assets discussed. Trading involves substantial risk of loss.

The following names ranked highest on a near-support + relative-strength screen (snapshot 2026-11-04 01:30). Focus is on the highest SCR scores that were sitting close to defined support (20-day, 40-day, 50-day SMA, or 200-day SMA) with relatively constructive risk tags. Entry zones are drawn around the listed support levels; stops are placed a modest distance below to allow for noise; targets are illustrative mean-reversion or prior-structure levels only.

Top Setups — Entry, Stop-Loss, Target, Potential Loss, Reward & Risk-Reward

Prices and levels from the 4 Nov 2026 snapshot. Potential loss and reward percentages are approximate (based on midpoint of entry zone to stop or target). Risk-reward is reward % ÷ loss %. These figures ignore fees, slippage, and the possibility that the setup fails.

Symbol Price Support Entry Zone Stop-Loss Potential Loss Target Potential Reward R:R Chart
BTC 33.85 33.64 (20d) 33.60 – 34.00 32.70 −3.2% 37.00 +9.5% 3.0 View
BBNX 15.90 15.87 (20d) 15.80 – 16.05 15.40 −3.3% 17.40 +9.4% 2.8 View
ASST 20.46 20.28 (40d) 20.25 – 20.60 19.70 −3.6% 22.40 +9.6% 2.7 View
AAPL 329.82 333.91 (s50) 328.50 – 332.00 320.00 −3.2% 355.00 +7.5% 2.3 View
ASML 1,526.14 1,518.00 (40d) 1,515 – 1,535 1,470 −3.6% 1,650 +8.2% 2.3 View
BTC-US 76,948 76,189 (40d) 76,000 – 77,200 73,800 −3.6% 83,500 +8.7% 2.4 View
CGAU 19.84 19.25 (40d) 19.30 – 20.00 18.70 −4.8% 21.80 +10.7% 2.2 View
GLD 360.39 354.67 (40d) 355 – 362 348 −2.9% 385 +7.4% 2.6 View
ARW 203.21 200.39 (40d) 200.50 – 204.00 195.50 −3.3% 220.00 +8.7% 2.6 View
CBSH 55.63 56.29 (s50) 55.40 – 56.40 54.00 −3.4% 60.50 +8.2% 2.4 View

Brief Notes on the Highest-Conviction Names

BTC (equity) — Highest SCR (94), Low Risk, Tight to 20-Day

The equity ticker BTC is sitting just above its 20-day level with RSI near 31. Very tight proximity and a Low risk tag make this one of the cleanest setups on the list. TradingView chart.

BBNX & ASST — High SCR, Low Risk, Extremely Close to Support

Both BBNX (20-day) and ASST (40-day) rank near the top of the screen with Low risk ratings and are within 1% of their support levels. These offer defined, nearby reference points for potential mean-reversion attempts.

AAPL & ASML — Large-Cap Names Testing Key Levels

AAPL is slightly under its 50-day SMA while ASML is just above its 40-day. Both carry medium-to-low risk tags and high SCR scores. Size and liquidity make them more straightforward to trade than smaller names, though they remain subject to broader market sentiment.

BTC-US & Precious-Metals Related (GLD, CGAU)

Bitcoin is testing a 40-day support zone near 76k with a Low risk tag and RSI of 28. GLD (starred) and CGAU continue to appear near 40-day levels in the metals complex. Confirmation of a hold remains important given recent precious-metals volatility.

How to Use This Table

  • Treat the entry zones as areas of interest, not precise buy triggers. Wait for price to stabilize or show a reversal candle near support.
  • The listed stop-losses are illustrative. Adjust for your own volatility tolerance and account size. Potential loss % is measured from the midpoint of the entry zone to the stop.
  • Potential reward % and R:R ratios are simple calculations only. They assume the target is reached and ignore path risk, fees, and the chance the stop is hit first.
  • Click any “View” link to open the live TradingView chart for the latest price action.
Final Disclaimer: Nothing in this post constitutes a recommendation to buy, sell, or hold any security or cryptocurrency. All data is historical as of the 4 November 2026 snapshot and may no longer be accurate. Markets can move sharply; support levels frequently break. Always perform independent due diligence and only risk capital you can afford to lose.

Published for educational purposes. Snapshot date: 4 November 2026. Charts linked via TradingView.

Comments

Post a Comment

Popular posts from this blog

X Accounts Traders To Follow

Navigating the Wild World of Trading Twitter: 14 Accounts Worth Watching in 2026 The trading scene on X (formerly Twitter) is chaotic—hype, real-time alerts, massive wins (and wipeouts). These accounts span penny stock momentum chasers, day traders, community builders, and macro news giants. Always DYOR: these are opinions only, high-risk space! Penny/Momentum Runner Spotters (High-Risk, High-Reward) These accounts flag low-float, volatile small-caps that can explode 100–400%+ in a session (e.g., recent $QNCX, $RENX runners). @Boytrader08 (~7k followers): Daytrader posting after-hours penny action, quick ideas/recaps on movers like $RENX, $AREB. @stomping_llama (~5.5k): "Trash penny stocks" skeptic—shorts, DD, anti-hype angles (e-book/blog links). @Mitch___Picks (~88k): 15+ years penny/crypto/options experience; casual takes, watchlists, modest engagement. @BeforeTheRocket (~13k): Parabolic swing ideas, "before they run...
Read more

ALLO

Swing Trade Playbook: ALLO for Monday, July 28, 2025 Disclaimer This swing trade playbook is crafted by @shaneman007 with assistance from Grok, an AI developed by xAI, using data as of August 28, 2025. Grok aims to provide accurate insights but may make errors. Trading is high-risk; conduct your own research and consult a financial advisor before acting. Past performance does not guarantee future results. Swing Trade Playbook: Allogene Therapeutics (ALLO) for Monday, July 28, 2025 Hey, swing traders! It’s @shaneman007, dropping a hot playbook for Allogene Therapeutics (ALLO) , a biotech penny stock primed for action. If you’re chasing 30–60% returns over 1–3 days like me, ALLO’s momentum and short-squeeze potential make it a must-watch for Monday, July 28, 2025. With Grok’s number-crunching, I’ve got a clear plan to help you score big while keeping risk tight. Let’s roll! Market Vibe: What’s the Buzz? ...
Read more

IXHL 🎰 Pack Your Moon Bags?

IXHL: A Simple “Lottery-Ticket” Roadmap (Not Financial Advice) IXHL: A Simple “Lottery-Ticket” Roadmap Here’s a straightforward and realistic speculative scenario map for IXHL based on historical trading behavior, current setup, and upcoming catalysts. These are scenarios only , not predictions — IXHL is a volatile micro-cap biotech at the $0.40 level, and movements tend to be extreme both directions. Scenario Breakdown Scenario Entry Zone First Target Stretch Target % Gain Time Frame Probability Trigger Quick Scalp / Oversold Bounce $0.39 – $0.42 $0.52 – $0.58 $0.65 +25% → +58% 1–10 days High (70%) Volume + short covering News Pop (trial update, partnership rumor, FDA notes) $0.40 – $0.45 $0.70 – $0.90 $1.20 – $1.50 +70% → +260% 1 day – 4 weeks Medium (40–50%) Real catalyst drop Short Squeeze + Gamma Ramp Un...
Read more